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A B S T R A C T
Objectives: To evaluate the expression of different matrix metalloproteinases (MMPs) and tissue
inhibitors of metalloproteinases (TIMPs) in vulvar lichen sclerosus (LS), a chronic dermatosis in women,
histologically characterized by a zone of collagen remodeling in the superior dermis.
Study design: Analysis of the expression of different MMPs (MMP-1, -2, -9 and -13) and TIMPs (TIMP-1
and -2) by reverse transcriptase-polymerase chain reaction (RT-PCR) in vulvar biopsies from patients
with LS (n = 11), classiﬁed according to Hewitt histological criteria and compared with clinically normal
vulvar tissue (n = 5), and the immunohistochemistry of MMP-2 and -9 and TIMP-1 and -2 distribution in
the remodeling zone of LS (n = 31) and in clinically normal vulvar tissue (n = 28).
Results: Although no statistically signiﬁcant difference between LS and normal skin groups at the mRNA
level of MMP and TIMP transcripts was shown, an increase in the immunodistribution of MMP-2 and -9
and TIMP-1 and -2 in LS compared to normal vulvar skin was observed.
Conclusions: These results suggest that these molecules could be related to the process of cutaneous
collagen remodeling in LS pathology.
 2011 Elsevier Ireland Ltd. 
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Matrix metalloproteinases (MMPs) are endopeptidases that are
capable of degrading the different macromolecular components of
the extracellular matrix (ECM). They play an important role in
tissue remodeling, wound healing, cancer invasion and inﬂamma-
tion. MMP activity is regulated by speciﬁc inhibitors (tissue
inhibitors of metalloproteinases, TIMPs), which contribute to
maintain the balance between ECM synthesis and degradation [1].
Lichen sclerosus (LS) is a chronic inﬂammatory disorder that
predominantly affects women in the perimenopausal and post-* Corresponding author at: Av. Carlos Chagas Filho S/N, Centro de Cieˆncias da
Sau´de, Instituto de Cieˆncias Biome´dicas, Programa de Biologia Celular e do
Desenvolvimento, Laborato´rio de Interac¸o˜es Celulares, Bloco F, sala F2-026,
Universidade Federal do Rio de Janeiro, Cidade Universita´ria, Ilha do Funda˜o,
CEP: 20941-590, Rio de Janeiro, Brazil. Fax: +55 21 2562 6483.
E-mail address: luiz.nasciutti@histo.ufrj.br (L.E. Nasciutti).
1 These authors contributed equally to this work.
0301-2115   2011 Elsevier Ireland Ltd. 
doi:10.1016/j.ejogrb.2011.12.003
Open access under the Elsevier OA license.menopausal years. The etiological hypothesis is that LS is a
multifactorial disorder, including genetic, hormonal and immuno-
logic factors. The association with organ-speciﬁc autoimmune
disease has resulted in LS being regarded as an autoimmune
phenomenon [2]. Indeed, circulating IgG autoantibodies to the
glycoprotein extracellular matrix protein 1 (ECM1) have been
demonstrated in the sera of about 75% of affected individuals [3],
and the passive transfer of afﬁnity-puriﬁed patient IgG led to some
histologic and immunopathologic features of LS skin [4].
The histologic classiﬁcation of LS was deﬁned in 1986, when the
collagen hyalinization zone of dermis was used as a grading system
for diagnosis [5]. However, the involvement of other components
of the ECM was also investigated in LS [6–8]. Probably the
alterations in the alignment of collagen ﬁbers [9] associated with
the interposition of glycoproteins [8], glycosaminoglycans, and
proteoglycans such as hyaluronan and chondroitin sulfate [6,10]
are responsible for the hyaline zone in LS disorder [11,12].
Moreover, association of these changes with signals of synthesis
and degradation of collagen ﬁbers [5], the absence of the elastic
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that changes in cell–cell and cell–ECM interactions followed by
catabolism of these ECM components, occur in LS tissue.
Nevertheless, little is known about the ECM remodeling system
in LS [7,14,15]. Here, we analyzed the expression of collagenases,
MMP-1 and MMP-13, the gelatinases, MMP-2 and MMP-9, the
tissue inhibitors, TIMP-1 and TIMP-2, and also the immunohis-
tochemistry distribution of MMP-2, MMP-9, TIMP-1 and TIMP-2 in
vulvar biopsies from patients with LS.
2. Materials and methods
2.1. Patient selection and sample collection
All vulvar LS biopsies were obtained in the Moncorvo Filho
Gynecology (MFG) Institute of the Federal University of Rio de
Janeiro (UFRJ), Brazil. Punch biopsies (4–6 mm) included vulvar
epidermis and dermis. LS biopsies (n = 31) were obtained from
untreated patients with LS conﬁrmed by histopathological
analysis. Control vulvar biopsies (n = 28) were obtained from
patients undergoing perineoplasty and/or corrective surgery for
labial hypertrophy. All subjects in the study signed an informed
consent to a research protocol that had been reviewed and
approved by the UFRJ MFG Ethics Committee (No. 06-2001).
2.2. Cell lines and culture conditions
Cell line cDNAs were used for polymerase chain reaction (PCR)
protocol optimization (Supplementary data 1). MDA435 adeno-
carcinoma cells and HL60 hematopoietic cells were grown in RPMI
1640 medium (Invitrogen, Paisley, UK) with 10% fetal calf serum.
KG-1 hematopoietic cells were grown in 80% Dulbecco’s Modiﬁed
Eagle’s Medium – DMEM (Sigma, St Louis, MO, USA) and 20% fetal
bovine serum. Gingival tissue was used for MMP-13 optimization
[16]. Cell lysis (107 cells) and RNA isolation were performed with
Trizol reagent (Invitrogen). PCR optimization protocols included
titrations of 20-deoxynucleoside 50-triphosphates (dNTPs), MgCl2
and primers to eliminate unspeciﬁc ampliﬁcations.
2.3. RNA isolation and cDNA synthesis
For RNA isolation, specimens were dissected and homogenized
in a 4 M guanidinium isothiocyanate solution (Life Technologies
Inc., Gaithersburg, NY, USA), containing 2-mercaptoethanol and
phenol. RNA extraction was performed according to Chomczynski
and Sacchi [17] followed by cDNA synthesis as previously
described [18].
2.4. Polymerase chain reactions (PCRs)
All PCRs were carried out with a thermocycler (T gradient,
Biometra, Germany) under conditions previously established [16]
and listed in Supplementary data 1. Ampliﬁed products were
visualized in 1.4% agarose gels stained with ethidium bromide. For
densitometric assays, digital photographs of the gels were
analyzed by the NIH Scion Image Program (version 1.62). Signals
of MMPs and TIMPs were normalized by glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) internal product.
2.5. Histology and immunohistochemistry
For histological and immunohistological study, biopsies were
ﬁxed in 10% buffered formaldehyde for 24 h and embedded in
parafﬁn. Sections of 5 mm thickness were obtained and stained
with hematoxylin–eosin and classiﬁed independently by Hewitt
criteria by two pathologists. For immunohistochemistry, sectionswere hydrated and subjected to heat-mediated antigen retrieval
for 4 min in 10 mM citric acid solution (pH 6.0). For endogenous
peroxidase inactivation, the sections were immersed in a 3% H2O2
solution in methanol for 15 min and washed twice with
phosphate-buffered saline (PBS, pH 7.4) – 0.5% Triton X-100
(Sigma, T8787) solution for 15 min each, followed by washing with
PBS. Then, unspeciﬁc binding of immunoglobulins with tissue
proteins was blocked by washing with PBS containing 5% bovine
serum albumin (BSA) (Sigma, A9647), 0.1% Triton X-100, 0.1%
Tween 20 (Sigma, P1379), followed by incubation with rabbit
polyclonal antibodies directed against MMP-2, MMP-9, TIMP-1
and TIMP-2 (Neomarkers code # Rb9233, 9234, 9204 and 9286,
Fremont, CA, USA, respectively), diluted in PBS containing 1% BSA,
0.1% NaN3, at the dilutions of 1:200, 1:200, 1:800 or 1:150,
respectively. As chromogen for peroxidase, di-amino-benzidine-
tetrahydrochloride (Liquid DAB, DAKO code # K3468) was used for
5 min at 37 8C. Samples were then counterstained with Harris
hematoxylin. Breast carcinoma, intestine adenoma and placenta
tissues were used as positive controls.
2.6. Image analyses and quantiﬁcation
Images were acquired using an Evolution MP color 5.0 CCD
video camera (Media Cybernetics, Silver Spring, EUA). The software
used for remote image capture and analyses was Image Pro-Plus
4.5 (Media Cybernetics, EUA). All images were captured at the
same exposure and digital gain settings. Quantitative analyses
(density area measurement) were carried out with the highest
immunoreactivity ﬁelds (hot-spot) using the 40 objective lens, in
a total of 10 microscopic ﬁelds. Remodeling zone of collagen and
inﬂammatory cells were selected for analyses in LE samples. For
the control group, superior dermis was selected. For semi-
quantitative analyses a microscopic numerical score was utilized
considering immunostained cells (epidermis and dermis were
considered) 1: 0–25% positive cells, 2: 25–75% positive cells, and 3:
more than 75% positive cells. For this approach, a 40 objective
lens was used.
2.7. Statistical analysis
All results were expressed as medians. Results were analyzed
using the Mann–Whitney nonparametric test. For correlation,
Spearman’s test was used. p < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Histologic classiﬁcation by Hewitt criteria
Based on the Hewitt classiﬁcation, in 31 analyzed samples we
found 21 cases of I.1 (67.74%), 1 case of I.2 (3.22%), 7 cases of II.1
(22.58%), 2 cases of II.2a (6.45%) and no cases corresponding to II.2b
classiﬁcation (Supplementary data 2). No disagreement was
observed in the pathologists’ analyses.
3.2. Gelatinases (MMP-2 and -9) are more expressed than
collagenases (MMP-1 and -13) in LS and normal skin
Speciﬁc cell lines were used for PCR establishment (Supple-
mentary data 3). In the LS group (n = 11), we observed expression
of MMP-1 in 9% of samples, MMP-2 in 63.6%, MMP-9 in 72.7% and
54.5% of samples for TIMP-1 and -2 (Table 1). MMP-13 expression
was not detected in analyzed samples. In the normal skin group
(n = 5), we observed 60% with MMP-2, 40% with MMP-9 and 60%
with TIMP-1 and -2. MMP-1 and -13 were not detected. Semi-
quantitative analyses of MMPs and TIMPs expression were not
Table 1
MMP and TIMP expression and densitometric analysis.
MMP-1 MMP-2 MMP-9 MMP-13 TIMP-1 TIMP-2
LS group (n = 11) 9% (1) 63.6% (7) 72.7% (8) (0) 54.5% (6) 54.5% (6)
Normal skin (n = 5) (0) 60% (3) 40% (2) (0) 60% (3) 60% (3)
Semi-quantitative analysis for LS group
Sample
1 0 0.609 0.360 0 0 0
2 0 0.482 0.413 0 0 0
3 0 0 0 0 0 0
4 0 0 0 0 0 0
5 0 0.517 0.407 0 0.428 0.565
6 0 0 0.332 0 0.405 0.654
7 0 0.408 0.383 0 0.795 0.806
8 0 0.373 0.388 0 0.510 0.484
9 0 0 0 0 0 0
10 0 0.282 0.565 0 0.357 0.443
11 0.315 0.612 0.748 0 0.539 0.684
Semi-quantitative analysis for normal skin group
Sample
1 0 0.770 0.600 0 0.946 0.917
2 0 0 0 0 0 0
3 0 0.630 0.529 0 0.812 0.385
4 0 0 0 0 0 0
5 0 0.437 0 0 0.337 0.385
Positive samples are given in parentheses.
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the different MMP classes (collagenases and gelatinases) was not
the same in controls and LS samples. Collagenases MMP-1 and -13
were less expressed (LS: 1 in 11 and control: 0 in 5 for MMP-1 plus -
13) than gelatinases MMP-2 and -9 (LS: 7 in 11, 8 in 11 and control:
3 in 5, 2 in 5 for MMP-2 and -9, respectively) in our studied
population (Table 1).
3.3. Keratinocytes, inﬂammatory and stromal cells are
immunopositive for gelatinases (MMP-2 and -9) and their tissue
inhibitors (TIMP-1 and -2) in LS
MMP-2 and MMP-9 were expressed in LS and the control
group; nevertheless, in LS the immunoreactivity seemed to be
more intense. MMP-2 was positive in all layers of the epidermis in
LS (Fig. 1A and B), and the reactivity was present in cytoplasm and
nuclei of keratinocytes. Mononuclear inﬂammatory inﬁltrate was
observed in LS with intense reactivity for MMP-2. Stromal cells
and vascular endothelium were also strongly positive in LS.
Normal skin showed a sparse mononuclear inﬂammatory inﬁl-
trate positive for MMP-2. However, MMP-9 was only detected in
the basal and Malpighi layers of the epidermis (Fig. 1C and D)
including some reactivity in nuclei. There was a tendency for
MMP-9 to be more intense in LS than in normal vulvar skin
samples. Inﬂammatory inﬁltrate and vascular endothelium were
reactive for MMP-9. In cases of LS with epidermal atrophy,
keratinocytes showed less reactivity for MMP-2 and -9 than
keratinocytes in controls. TIMP-1 (Fig. 1E and F) and -2 (Fig. 1G
and H) were also expressed in LS and normal skin. In LS, epidermis
showed moderate immunopositivity in all layers for TIMP-1 and -
2. Nuclear immunopositivity for TIMP-1 and -2 was more intense
in keratinocytes of LS than in normal skin. Inﬂammatory inﬁltrate,
vascular endothelium and stromal cells of LS showed more
reactivity for TIMP-1 and -2 than normal skin, but the signal was
weak for TIMP-1 and strong for TIMP-2.
Statistical analyses showed that LS samples had the greatest
number of keratinocytes, inﬂammatory and stromal cells immu-
nopositive for MMP-2, -9 and TIMP-1 and -2 compared to normal
skin samples (p < 0.05) (Fig. 2A–C), and in both LS and normal skin,
more inﬂammatory cells than stromal cells were reactive for MMP-
2, -9 and TIMP-2 (p < 0.05 in all comparisons). In LS, more
inﬂammatory cells than stromal cells were reactive for TIMP-1;however, in normal skin, more stromal cells than inﬂammatory
cells were immunopositive for TIMP-1 (p < 0.05) (Fig. 2B and C).
Densitometric evaluation of immunopositive area for MMPs
showed that in LS samples, there was a greater density (p < 0.001)
for all MMPs (MMP-2 and -9) and TIMPs (TIMP-1 and -2) than in
controls (Fig. 2D). The immunopositive density for MMP-2 and -9
was similar in LS (medians of 3.938 and 4.506, respectively) and in
normal skin (medians 0.07 for both). However, there was a greater
density for TIMP-2 in relation to TIMP-1 in LS samples (medians of
1.46 and 0.04, respectively), while in normal skin samples TIMP-1
and -2 were similar (medians of 0.009 and 0, respectively). We
found a direct positive correlation between the density of
immunopositivity for MMP-2 and that of MMP-9 in LS as well
as in normal skin (R = 0.63 and R = 0.91 respectively, p < 0.001 for
both), and between TIMP-1 and -2 in LS (R = 0.84, p < 0.001) (data
not shown). We found no correlation between TIMP-1 and -2 in
normal skin and no other correlations between MMPs versus
TIMPs.
4. Comment
Our results showed no statistically signiﬁcant difference
between LS and normal skin groups at the mRNA level of MMP
and TIMP transcripts. Due to sample size limitations, Western blot
data were not collected; however, immunodistribution analysis for
MMP-2 and -9 and TIMP-1 and -2 showed signiﬁcant differences
between the groups. These results can be explained by immuno-
reactivity of activated keratinocytes, endothelial cells, ﬁbroblasts
and inﬂammatory cells. All cases of LS and normal skin showed
some level of immunostaining for MMP-2 and -9 and TIMP-1 and -
2, although transcripts of these MMPs were not detected in all
samples. Since vulvar LS is a focal lesion, fragments of the same
sample are not always homogeneous, thus giving differences in
results at the protein and mRNA levels. Based on in situ
hybridization, there was also no correlation between expression
of MMP-2 and -9 or TIMP-1 and -2 and localization of these
enzymes in non-melanocytic tumors and normal skin [19].
mRNA expression for MMP-13 was not present in LS and normal
skin, and in one case of LS for MMP-1. MMP-13 expression is
commonly associated with a malignant phenotype of keratino-
cytes of squamous carcinoma of head and neck and vulva [20,21]. It
may be that the low expression of MMP-1 and -13 in LS is
Fig. 1. Immunostaining in LS patients and normal skin. Stained sections observed in LS and normal skin for MMP-2, -9 and TIMP-1 and -2. (A) MMP-2 in LS shows diffuse
immunostaining in epidermis, vessels and lymphocytes from the hyalinization zone. (B) Normal skin with weak reactivity. (C) MMP-9 in LS with diffuse immunostaining in
epidermis. (D) Normal skin with weak reactivity. (E) TIMP-1 with diffuse and moderate immunostaining in LS. (F) Normal skin with weak reactivity. (G) TIMP-2 in LS shows
immunostaining in all layers of epidermis. (H) Normal skin with weak reactivity. Insets represent negative controls for each antibody analyzed (magniﬁcation: a, c, e, 100; b,
d, f, h, 200; g, 400).
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Fig. 2. Semi-quantitative analysis in LS patients and normal skin. Semi-quantitative evaluation of immunostaining for MMP-2, -9 and TIMP-1 and -2 according to a score of 1–
3 (1: 0–25% positive cells, 2: 25–75% positive cells and 3: more than 75% of positive cells) in all samples of LS and normal skin. (A) Keratinocytes, (B) inﬂammatory cells, (C)
stromal cells. (D) Immunopositivity analyzed by densitometry of immunohistochemical markers.
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hyalinization zone [22].
MMP-2 and -9 evaluations showed a higher density of these
proteins in LS than in normal skin. A previous report showed no
difference between LS and normal skin in a comparison based on
MMP-2 reactivity in stromal cells [15]; however, our evaluation
also included inﬂammatory cells and vessels present in the
hyalinization zone. The presence of MMP-2 in the remodeling zone
of LS may explain the described decrease in decorin expression in
the most compact areas of the hyalinization zone of LS [6]. Less
compact areas showed a higher expression of decorin, in contrast
to absence of expression in normal skin [6]. Decorin is more
efﬁciently degraded by MMP-2 than MMP-1 and -9 [23]. The
conﬂicting results regarding collagen synthesis suggest different
stages of ﬁbrillogenesis.
In LS, TIMP-1 and -2 reactivities were greater than those in
normal skin. Undetectable levels of TIMP-2 and no differences
between cutaneous basal cell carcinoma and normal skin have
already been shown by MMP-1, -2, and -9 and TIMP-1
immunostaining [24]. This discrepancy in TIMP activity may
contribute to local invasion of this tumor and it could also occur in
LS. Vulvar LS cultured cells also showed increased collagenase
inhibitor levels [14], conﬁrming our results. MMPs and TIMPs are
activated in the extracellular environment and are found
predominantly in the active form in ECM [25,26]. In some cases
of LS we observed the presence of TIMP-1 and -2 in the dermal ECM
and no deposition of MMP-2 and -9, suggesting that MMPs and
TIMPs may be expressed asynchronously in LS. MMP-2 and -9 were
also reactive in keratinocytes, inﬂammatory and stromal cells in LS.
These results could explain the changes in the basal membrane,since these MMPs degrade mainly laminin and type IV collagen.
The direct and positive correlation between protein expression of
MMP-2 versus -9 and TIMP-1 versus -2 in LS, suggests that
activation factors for expression of gelatinases and TIMPs are the
same [8,27,28].
Curiously, nuclear immunostaining of keratinocytes was
observed for MMP-2 and -9 and TIMP-1 and -2 in LS and normal
skin. These ﬁndings are consistent with results shown in nuclei of
normal and neoplastic cells, in which MMP-2 and -3 and TIMP-1
reactivities are present [29,30]. Nuclear localization of TIMP-1 and
MMP-3 may be related to the proteolytic cleavage of nuclear
matrix in processes such as apoptosis and cell cycle regulation [30].
In LS, an initially hyperplasic epidermis is followed by a process of
keratinocyte death, probably due to increased apoptosis and
therefore an increase in the amount of MMP in the nucleus.
This work provides support to the suggestion that the
remodeling system of ECM (represented in this work by MMPs
and TIMPs) is involved in the pathogenesis of LS, and also that LS
represents a good model for studying the expression and
distribution of MMPs and TIMPs in the process of cutaneous
collagen remodeling. New insights focused on the degradation of
ECM in LS must be brought to bear on questions such as the
molecular factors involved in expression and secretion of MMPs
and TIMPs and the mechanisms involved in the evolution of this
intriguing disorder of unknown etiology.
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